癌症治疗中的转运屏障与肿瘤物理学
Transport Barriers and Oncophysics in Cancer Treatment.
作者信息
Nizzero Sara, Ziemys Arturas, Ferrari Mauro
机构信息
Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA; Applied Physics Graduate Program, Smalley-Curl Institute, Rice University, Houston, TX 77005, USA.
Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
出版信息
Trends Cancer. 2018 Apr;4(4):277-280. doi: 10.1016/j.trecan.2018.02.008. Epub 2018 Mar 15.
Abstract
Transport processes in cancer are the focus of transport oncophysics (TOP). In the TOP approach, the sequential negotiation of transport barriers is critical to both drug delivery and metastasis development. New and creative therapeutic opportunities are currently emerging, stimulated by the study of cancer hallmarks with the TOP approach.
摘要
癌症中的转运过程是转运肿瘤物理学（TOP）的研究重点。在TOP方法中，转运屏障的连续突破对于药物递送和转移发展都至关重要。目前，受TOP方法对癌症特征研究的推动，新的、有创造性的治疗机会正在涌现。
相似文献
1
Transport Barriers and Oncophysics in Cancer Treatment.
Trends Cancer. 2018 Apr;4(4):277-280. doi: 10.1016/j.trecan.2018.02.008. Epub 2018 Mar 15.
2
Transport Oncophysics in silico, in vitro, and in vivo. Preface.
Phys Biol. 2014 Nov 26;11(6):060201. doi: 10.1088/1478-3975/11/6/060201.
3
Targeting Biophysical Cues: a Niche Approach to Study, Diagnose, and Treat Cancer.
Trends Cancer. 2018 Apr;4(4):268-271. doi: 10.1016/j.trecan.2018.02.006. Epub 2018 Mar 12.
4
Why I'm Holding onto Hope for Nano in Oncology.
Mol Pharm. 2016 Aug 1;13(8):2603-4. doi: 10.1021/acs.molpharmaceut.6b00547. Epub 2016 Jul 15.
5
Barriers to drug delivery in interventional oncology.
J Vasc Interv Radiol. 2013 Aug;24(8):1201-7. doi: 10.1016/j.jvir.2013.03.034. Epub 2013 Jun 2.
6
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Drug Resist Updat. 2011 Jun;14(3):150-63. doi: 10.1016/j.drup.2011.01.003. Epub 2011 Feb 16.
7
Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.
Trends Cancer. 2018 Apr;4(4):292-319. doi: 10.1016/j.trecan.2018.02.005. Epub 2018 Mar 13.
8
9
Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment.
Med Res Rev. 2020 May;40(3):1084-1102. doi: 10.1002/med.21644. Epub 2019 Nov 11.
10
Programmable nanomedicine: synergistic and sequential drug delivery systems.
Nanoscale. 2015 Feb 28;7(8):3381-91. doi: 10.1039/c4nr07677j.
引用本文的文献
1
Controlled and orthogonal partitioning of large particles into biomolecular condensates.
Nat Commun. 2025 Apr 14;16(1):3521. doi: 10.1038/s41467-025-58900-5.
2
Nanotechnology-based drug delivery system for the diagnosis and treatment of ovarian cancer.
Discov Oncol. 2025 Mar 29;16(1):422. doi: 10.1007/s12672-025-02062-9.
3
Extracellular vesicle gatekeepers for tumours.
Nat Mater. 2024 Dec;23(12):1618-1619. doi: 10.1038/s41563-024-02049-x.
4
Nanotechnology for boosting ovarian cancer immunotherapy.
J Ovarian Res. 2024 Oct 14;17(1):202. doi: 10.1186/s13048-024-01507-z.
5
Stick, Slide, or Bounce: Charge Density Controls Nanoparticle Diffusion.
ACS Nano. 2024 Oct 22;18(42):28636-28648. doi: 10.1021/acsnano.4c05077. Epub 2024 Oct 8.
6
An Insight into Perfusion Anisotropy within Solid Murine Lung Cancer Tumors.
Pharmaceutics. 2024 Jul 30;16(8):1009. doi: 10.3390/pharmaceutics16081009.
7
Controlled and orthogonal partitioning of large particles into biomolecular condensates.
bioRxiv. 2024 Jul 16:2024.07.11.603072. doi: 10.1101/2024.07.11.603072.
8
Recent Advances in Whiskers: Properties and Clinical Applications in Dentistry.
Int J Nanomedicine. 2024 Jul 12;19:7071-7097. doi: 10.2147/IJN.S471546. eCollection 2024.
9
From bone to nanoparticles: development of a novel generation of bone derived nanoparticles for image guided orthopedic regeneration.
Biomater Sci. 2024 Jul 9;12(14):3633-3648. doi: 10.1039/d4bm00391h.
10
Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy.
ACS Omega. 2024 Feb 5;9(7):7277-7295. doi: 10.1021/acsomega.3c06501. eCollection 2024 Feb 20.
本文引用的文献
1
A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery.
Sci Rep. 2017 Oct 23;7(1):13738. doi: 10.1038/s41598-017-14221-2.
2
Functional precision cancer medicine-moving beyond pure genomics.
Nat Med. 2017 Sep 8;23(9):1028-1035. doi: 10.1038/nm.4389.
3
An injectable nanoparticle generator enhances delivery of cancer therapeutics.
Nat Biotechnol. 2016 Apr;34(4):414-8. doi: 10.1038/nbt.3506. Epub 2016 Mar 14.
4
Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier.
J Control Release. 2015 Nov 10;217:293-9. doi: 10.1016/j.jconrel.2015.09.044. Epub 2015 Sep 25.
5
Principles of nanoparticle design for overcoming biological barriers to drug delivery.
Nat Biotechnol. 2015 Sep;33(9):941-51. doi: 10.1038/nbt.3330.
6
Computational analysis of drug transport in tumor microenvironment as a critical compartment for nanotherapeutic pharmacokinetics.
Drug Deliv. 2016 Sep;23(7):2524-2531. doi: 10.3109/10717544.2015.1022837. Epub 2015 Apr 2.
7
Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment.
Cancer Res. 2014 Aug 15;74(16):4239-46. doi: 10.1158/0008-5472.CAN-13-3494. Epub 2014 May 22.
8
What does physics have to do with cancer?
Nat Rev Cancer. 2011 Aug 18;11(9):657-70. doi: 10.1038/nrc3092.
9
Hallmarks of cancer: the next generation.
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
10
Frontiers in cancer nanomedicine: directing mass transport through biological barriers.
Trends Biotechnol. 2010 Apr;28(4):181-8. doi: 10.1016/j.tibtech.2009.12.007. Epub 2010 Jan 14.
Zotero 插件